Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation-Reference-Cited by-同舟云学术

Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation

Published:2018-05-24 Issue:12 Volume:107 Page:1111-1121
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Liu Dan,Hu Kai,Schmidt Marie,Müntze Jonas,Maniuc Octavian,Gensler Daniel,Oder Daniel,Salinger Tim,Weidemann Frank,Ertl Georg,Frantz Stefan,Wanner Christoph,Nordbeck Peter

Funder

the Bundesministerium für Bildung und Forschung

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s00392-018-1285-4/fulltext.html

Reference46 articles.

1. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346

2. Mehta A, Ginsberg L (2005) Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Suppl 94:24–27 (discussion 29 - 10)

3. Oder D, Uceyler N, Liu D, Hu K, Petritsch B, Sommer C, Ertl G, Wanner C, Nordbeck P (2016) Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. BMJ Open 6:e010422